Cargando…

Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections

This article provides a comprehensive review of currently available treatment options for infections due to carbapenem-resistant Enterobacteriaceae (CRE). Antimicrobial resistance in Gram-negative bacteria is an emerging and serious global public health threat. Carbapenems have been used as the “las...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morrill, Haley J., Pogue, Jason M., Kaye, Keith S., LaPlante, Kerry L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2015
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462593/ https://www.ncbi.nlm.nih.gov/pubmed/26125030 http://dx.doi.org/10.1093/ofid/ofv050

Ejemplares similares

Overview of meropenem-vaborbactam and newer antimicrobial agents for the treatment of carbapenem-resistant Enterobacteriaceae
por: Petty, Lindsay A, et al.
Publicado: (2018)

Cefiderocol, a Siderophore Cephalosporin, as a Treatment Option for Infections Caused by Carbapenem-Resistant Enterobacterales
por: Kaye, Keith S., et al.
Publicado: (2023)

2550. Comparing Efficacy of Serum and Epithelial Lining Fluid Concentrations for Meropenem Against Carbapenem-Resistant Enterobacterales
por: Lavoie, Thomas, et al.
Publicado: (2023)

Treatment for infections with carbapenem-resistant Enterobacteriaceae: what options do we still have?
por: Yamamoto, Michele, et al.
Publicado: (2014)

Infections Caused by Carbapenem-Resistant Enterobacteriaceae: An Update on Therapeutic Options
por: Sheu, Chau-Chyun, et al.
Publicado: (2019)

Emerging Carbapenem-Resistant Enterobacteriaceae Infection, Its Epidemiology and Novel Treatment Options: A Review
por: Tilahun, Mihret, et al.
Publicado: (2021)

Predictors of 30-day All-cause Mortality in Veterans with First Recurrence of Clostridium difficile Infection (CDI)
por: Morrill, Haley, et al.
Publicado: (2017)

Therapeutic Options for the Treatment of Carbapenem-resistant Enterobacteriaceae Infections: Hope in the Times of Hype and Despair
por: Ansari, Abdul S
Publicado: (2021)

The Role of Trimethoprim/Sulfamethoxazole in the Treatment of Infections Caused by Carbapenem-Resistant Enterobacteriaceae
por: Luterbach, Courtney L, et al.
Publicado: (2018)

2410. Clinical Outcomes Associated With Various Treatment Options for Infections Caused by Carbapenem-Resistant Enterobacteriaceae
por: Bandali, Aiman, et al.
Publicado: (2018)

Antimicrobial stewardship program prompts increased and earlier infectious diseases consultation
por: Morrill, Haley J, et al.
Publicado: (2014)

Carbapenem-Resistant Enterobacteriaceae Infections in Patients on Renal Replacement Therapy
por: Eilertson, Brandon, et al.
Publicado: (2017)

Present and Future of Carbapenem-resistant Enterobacteriaceae (CRE) Infections
por: Suay-García, Beatriz, et al.
Publicado: (2019)

Treatment of Carbapenem-Resistant Enterobacteriaceae Infections with Ceftazidime-Avibactam
por: Rahmati, Elham, et al.
Publicado: (2017)

Erratum to: Epidemiology of Pneumococcal Disease in a National Cohort of Older Adults
por: Morrill, Haley J., et al.
Publicado: (2014)

Epidemiology of Pneumococcal Disease in a National Cohort of Older Adults
por: Morrill, Haley J., et al.
Publicado: (2014)

Bloodstream infections due to Carbapenem-Resistant Enterobacteriaceae in hematological patients: assessment of risk factors for mortality and treatment options
por: Zhang, Lining, et al.
Publicado: (2023)

Deaths Attributable to Carbapenem-Resistant Enterobacteriaceae Infections
por: Falagas, Matthew E., et al.
Publicado: (2014)

Carbapenem-Resistant Enterobacteriaceae Infections: Taiwan Aspects
por: Jean, Shio-Shin, et al.
Publicado: (2018)

Resistance Pattern of Carbapenem on Enterobacteriaceae
por: Pokharel, Khilasa, et al.
Publicado: (2018)

Impact of a Prospective Audit and Feedback Antimicrobial Stewardship Program at a Veterans Affairs Medical Center: A Six-Point Assessment
por: Morrill, Haley J., et al.
Publicado: (2016)

Epidemiology of Carbapenem-Resistant Enterobacteriaceae at a Long-term Acute Care Hospital
por: Chopra, Teena, et al.
Publicado: (2018)

1585. Stenotrophomonas maltophilia Infections and Approaches to Treatment
por: Caffrey, Aisling, et al.
Publicado: (2020)

1610. Epidemiology and Treatment Heterogeneity in Acinetobacter baumanii Infections
por: Caffrey, Aisling, et al.
Publicado: (2020)

Carbapenem Resistant Enterobacteriaceae infections in Houston, Texas: An outline
por: Rehman, Hafeez, et al.
Publicado: (2017)

Vital Signs: Carbapenem-Resistant Enterobacteriaceae
por: Jacob, Jesse T., et al.
Publicado: (2013)

Efficacy of ceftazidime-avibactam in the treatment of infections due to Carbapenem-resistant Enterobacteriaceae
por: Alraddadi, Basem M., et al.
Publicado: (2019)

The Infinity War: How to Cope with Carbapenem-resistant Enterobacteriaceae
por: Yoo, Jin-Hong
Publicado: (2018)

Evaluation of Resistance Mechanisms in Carbapenem-Resistant Enterobacteriaceae
por: Alizadeh, Naser, et al.
Publicado: (2020)

Carbapenem-resistant Acinetobacter baumannii: Colonization, Infection and Current Treatment Options
por: Bartal, Carmi, et al.
Publicado: (2022)

470. Concomitant Antibiotic Use and Death Among a National Cohort of Veterans With Clostridium difficile Infection (CDI)
por: Appaneal, Haley, et al.
Publicado: (2018)

2416. Risk Factors and Outcomes of Bacteremia Caused by Carbapenem-Resistant Enterobacteriaceae Compared With Carbapenem Susceptible Enterobacteriaceae
por: Mahmood, Syed Faisal
Publicado: (2018)

192 Vancomycin Dosing in Obese and Morbidly Obese Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Pneumonia
por: Morrill, Haley, et al.
Publicado: (2014)

Prevention and management of carbapenem-resistant Enterobacteriaceae in haematopoietic cell transplantation
por: Sahitya, Dangudubiyyam Sri Krishna, et al.
Publicado: (2021)

Risk factor for mortality associated with carbapenem-resistant Enterobacteriacea infections
por: Carrilho, Cláudia MDM, et al.
Publicado: (2013)

Socioeconomic Burden of Bloodstream Infections Caused by Carbapenem-Resistant Enterobacteriaceae
por: Zhu, Yunying, et al.
Publicado: (2021)

Factors associated with acquisition of carbapenem-resistant Enterobacteriaceae
por: Lavagnoli, Lilian Silva, et al.
Publicado: (2017)

369 Outcomes of Patients with Carbapenem-Resistant Enterobacteriaceae
por: Raybould, Jillian, et al.
Publicado: (2014)

Emerging superbugs: The threat of Carbapenem Resistant Enterobacteriaceae
por: Dong, Le Thanh, et al.
Publicado: (2020)

Intestinal Dysbiosis in Carriers of Carbapenem-Resistant Enterobacteriaceae
por: Korach-Rechtman, Hila, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nh30oue5b55dr5oc6eks0r1r7o